A. Handisurya, “Anogenital Human Papillomavirus Prevalence is Unaffected by Therapeutic Tumour Necrosis Factor-alpha Inhibition”, Acta Derm Venereol, vol. 96, no. 4, pp. 494–498, Dec. 2015.